So I'll admit to being quite conflicted when it comes to $TLX @mikebrisy & @topowl. I do like the strategy and possible treatment products (yet to be approved of course) for kidney, prostate & brain and I believe the current missed approval was overreacted to by shareholders (so my time to buy as I had been watching an entry price for some time). The conflicted comes from personal experience and use of their isotope solution using Gallium 68 for my own PSMA PET Scan at iMed. Unfortunately, it was a failure in my case and the best summary stated inconclusive!!
On the other hand, another PSMA PET solution using F18 DCFPyL via Qscan worked great when recently undertaken before my prostatectomy.
I'll put it down to "horses for courses" (I think the stats say approx 15% have no postive reaction to Gallium 68 type solutions, or so my Urologist said) as I do like the $TLX story, so hopefully I don't get to trial any more of their products, but if I do, that they actually work for me!!
That said, my Urologist was pretty sure Qscan would get an outcome, which they did, but also to be fair to iMed and Gallium 68, Qscan knew that solution did not work, so they went with the more onerous 2.5 injection of F18 and got the desired result.
Anyway, still bought $TLX in SM portfolio, but will continue to watch closely as a shareholder, not a patient!!